ACAD vs. TPR

Last updated Apr 1, 2026

Compare and contrast key facts about ACADIA Pharmaceuticals Inc. (ACAD) and Tapestry, Inc. (TPR).

Performance

ACAD vs. TPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ACADIA Pharmaceuticals Inc. (ACAD) and Tapestry, Inc. (TPR). The values are adjusted to include any dividend payments, if applicable.

ACAD vs. TPR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ACAD ACADIA Pharmaceuticals Inc.	-16.66%	45.56%	-41.39%	96.67%	-31.79%	-56.34%	24.96%	164.56%	-46.30%	4.40%
TPR Tapestry, Inc.	10.74%	98.73%	82.80%	0.16%	-3.32%	32.29%	16.86%	-15.97%	-22.09%	30.48%

Fundamentals

Market Cap ACAD : $3.81B TPR : $29.60B
EPS ACAD : $2.30 TPR : $2.47
PE Ratio ACAD : 9.69 TPR : 57.01
PS Ratio ACAD : 3.54 TPR : 3.96
PB Ratio ACAD : 3.11 TPR : 53.71
Total Revenue (TTM) ACAD : $1.07B TPR : $7.51B
Gross Profit (TTM) ACAD : $500.82M TPR : $5.71B
EBITDA (TTM) ACAD : $122.49M TPR : $874.90M

Returns By Period

In the year-to-date period, ACAD achieves a -16.66% return, which is significantly lower than TPR's 10.74% return. Over the past 10 years, ACAD has underperformed TPR with an annualized return of -2.50%, while TPR has yielded a comparatively higher 16.40% annualized return.

ACAD

• 1D: 5.65%
• 1M: -9.36%
• YTD: -16.66%
• 6M: 4.31%
• 1Y: 34.02%
• 3Y*: 5.76%
• 5Y*: -2.75%
• 10Y*: -2.50%

TPR

• 1D: 3.06%
• 1M: -8.99%
• YTD: 10.74%
• 6M: 25.40%
• 1Y: 103.31%
• 3Y*: 52.33%
• 5Y*: 31.31%
• 10Y*: 16.40%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ACAD vs. TPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACAD

ACAD Risk / Return Rank: 66
ACAD Sharpe Ratio Rank: 67
ACAD Sortino Ratio Rank: 68
ACAD Omega Ratio Rank: 63
ACAD Calmar Ratio Rank: 66
ACAD Martin Ratio Rank: 65

TPR

TPR Risk / Return Rank: 93
TPR Sharpe Ratio Rank: 94
TPR Sortino Ratio Rank: 89
TPR Omega Ratio Rank: 92
TPR Calmar Ratio Rank: 95
TPR Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACAD vs. TPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and Tapestry, Inc. (TPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ACAD	TPR	Difference
Sharpe ratio Return per unit of total volatility	0.71	2.46	-1.75
Sortino ratio Return per unit of downside risk	1.51	2.71	-1.20
Omega ratio Gain probability vs. loss probability	1.17	1.43	-0.26
Calmar ratio Return relative to maximum drawdown	1.10	5.49	-4.38
Martin ratio Return relative to average drawdown	2.55	15.46	-12.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ACAD vs. TPR - Sharpe Ratio Comparison

The current ACAD Sharpe Ratio is 0.71, which is lower than the TPR Sharpe Ratio of 2.46. The chart below compares the historical Sharpe Ratios of ACAD and TPR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ACAD	TPR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.71	2.46	-1.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.79	-0.84
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.04	0.37	-0.41
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.45	-0.38

Correlation

The correlation between ACAD and TPR is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ACAD vs. TPR - Dividend Comparison

ACAD has not paid dividends to shareholders, while TPR's dividend yield for the trailing twelve months is around 1.10%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ACAD ACADIA Pharmaceuticals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TPR Tapestry, Inc.	1.10%	1.17%	2.14%	3.53%	2.89%	1.23%	1.09%	5.01%	3.00%	3.06%	3.85%	4.13%

Drawdowns

ACAD vs. TPR - Drawdown Comparison

The maximum ACAD drawdown since its inception was -96.29%, which is greater than TPR's maximum drawdown of -82.55%. Use the drawdown chart below to compare losses from any high point for ACAD and TPR.

Drawdown Indicators

	ACAD	TPR	Difference
Max Drawdown Largest peak-to-trough decline	-96.29%	-82.55%	-13.74%
Max Drawdown (1Y) Largest decline over 1 year	-27.58%	-18.92%	-8.66%
Max Drawdown (5Y) Largest decline over 5 years	-57.87%	-44.99%	-12.88%
Max Drawdown (10Y) Largest decline over 10 years	-77.18%	-79.06%	+1.88%
Current Drawdown Current decline from peak	-60.95%	-11.84%	-49.11%
Average Drawdown Average peak-to-trough decline	-50.06%	-27.86%	-22.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.94%	6.71%	+5.23%

Volatility

ACAD vs. TPR - Volatility Comparison

ACADIA Pharmaceuticals Inc. (ACAD) has a higher volatility of 13.50% compared to Tapestry, Inc. (TPR) at 9.72%. This indicates that ACAD's price experiences larger fluctuations and is considered to be riskier than TPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ACAD	TPR	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.50%	9.72%	+3.78%
Volatility (6M) Calculated over the trailing 6-month period	27.50%	26.36%	+1.14%
Volatility (1Y) Calculated over the trailing 1-year period	48.41%	42.23%	+6.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	56.19%	39.89%	+16.30%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	62.38%	43.96%	+18.42%

Financials

ACAD vs. TPR - Profitability Comparison

The chart below illustrates the profitability comparison between ACADIA Pharmaceuticals Inc. and Tapestry, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ACAD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ACADIA Pharmaceuticals Inc. reported a gross profit of -223.93M and revenue of 283.99M. Therefore, the gross margin over that period was -78.9%.

TPR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Tapestry, Inc. reported a gross profit of 1.89B and revenue of 2.50B. Therefore, the gross margin over that period was 75.5%.

ACAD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ACADIA Pharmaceuticals Inc. reported an operating income of 17.39M and revenue of 283.99M, resulting in an operating margin of 6.1%.

TPR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Tapestry, Inc. reported an operating income of 716.40M and revenue of 2.50B, resulting in an operating margin of 28.6%.

ACAD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ACADIA Pharmaceuticals Inc. reported a net income of 273.57M and revenue of 283.99M, resulting in a net margin of 96.3%.

TPR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Tapestry, Inc. reported a net income of 561.30M and revenue of 2.50B, resulting in a net margin of 22.4%.